Ciphergen, Bio-Rad Sued Over SELDI Sale, Suit Alleges Violation of 2003 Settlement

Molecular Analytical Systems alleges that it never consented to Ciphergen’s sale of the SELDI technology to Bio-Rad, as stipulated in a 2003 agreement reached by Ciphergen and MAS.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories